Resources

Consult our studies

Discover OWL Metabolomics contribution to scientific knowledge in our Resources section. We invite you to consult the publications in which we have participated, offering crucial insights into different therapeutic areas. Our library is here to help you with your research needs. We encourage you to explore our contributions with our extensive resources at your disposal. Use the filter options to search information by year of publication, therapeutic area, and/or disease.

Area

Aging Andrology Basic science Cardiology Cardiovascular Dermatology Ecology Endocrinology Fertility Gastroenterology / Hepatology Gynecology Inmunology Metabolomics Neuroscience Nutrition Oncology Ophtalmology Rare Disease

Disease

Acute intermittent porphyria Acute myeloid leukemia Aging Alcoholic Hepatitis Alzheimer’s Disease Amyotrophic lateral sclerosis Andrology Atopic dermatitis Bile acid diarrhoea Cardiovascular disease Cholangiocarcinoma Chronic venous disease Cirrhosis Colorectal cancer Cushing syndrome DILI Diabetes Diet in gestation Ecology Ferroptosis Fertility Fuchs endothelial dystrophy Glaucoma HIV Heart failure with preserved ejection fraction Hepatitis C Hepatoblastoma Hepatocellular carcinoma Hypercholesterolemia Infant Citrullinemia Type 1 Inflammation Intervertebral disc degeneration Lipodistrophy Liver fibrosis MASLD/MASH Membrane biophysics Metabolomics Multiple sclerosis Nutrition Obesity Ovarian endometriosis Pancreatic cancer Pancreatic ductal adenocarcinoma Parkinson’s Disease Pharmacometabolomics Physical frailty Primary sclerosing cholangitis Prostate cancer Schwann cell myelination Toxicity Vaccinia Virus Infection Vascular disease Wilson’s disease

Year

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2008

Reset filters

Lipidomic signatures from physically frail and robust older adults at hospital admission

GeroScience2022;44(3):1677-88 / 2022
Area: Aging
Disease: Physical frailty

Cardiometabolic effects of sacubitril/valsartan in a rat model of heart failure with preserved ejection fraction

Biochem Pharmacol 2024;230(Pt1):116571 / 2024
Area: Cardiology / Cardiovascular
Disease: Heart failure with preserved ejection fraction

Oleoylethanolamide mitigates cardiometabolic disruption secondary to obesity induced by high-fat diet in mice.

Life Sciences 2024;359:123226 / 2024
Area: Cardiology / Cardiovascular & Endocrinology
Disease: Cardiovascular disease and Obesity

Loss of peroxiredoxin 6 (PRDX6) alters lipid composition and distribution resulting in increased sensitivity to ferroptosis.

Biochem J. 2024 (in press) / 2024
Area: Oncology and Gastroenterology / Hepatology
Disease: Ferroptosis

Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind,randomised, placebo-controlled, phase 2b trial.

Lancet Gastroenterol Hepatol 2024;9(12):1090-100 / 2024
Area: Gastroenterology / Hepatology
Disease: MASLD/MASH

Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates.

Gut 2024 (in press) / 2024
Area: Rare Disease
Disease: Acute intermittent porphyria

Gene Therapy in Combination with Nitrogen Scavenger Pretreatment Corrects Biochemical and Behavioral Abnormalities of Infant Citrullinemia Type 1 Mice.

Int J Mol Sci. 2022;23(23):14940 / 2022
Area: Rare Disease
Disease: Infant Citrullinemia Type 1

Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans.

Cardiovasc Res. 2024;120(7):708-22. / 2024
Area: Cardiology / Cardiovascular
Disease: Cardiovascular disease

NAFLD and type 2 diabetes: A practical guide for the joint management.

Gastroenterol Hepatol. 2023;46(10):815-25. / 2023
Area: Gastroenterology / Hepatology & Endocrinology
Disease: MASLD/MASH and T2DM

Human recombinant relaxin-2 (serelaxin) regulates the proteome, lipidome, lipid metabolism and inflammatory profile of rat visceral adipose tissue

Biochem Pharmacol 2024;223:116157 / 2024
Area: Cardiology / Cardiovascular
Disease: Cardiovascular disease

An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

Nat Metab 2024; 6(6):1178-96 / 2024
Area: Gastroenterology / Hepatology
Disease: MASLD/MASH

Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol

Contemp Clin Trials. 2023;134;107352 / 2023
Area: Gastroenterology / Hepatology
Disease: MASLD/MASH

1 2 … 15 >

Our site uses cookies to collect information about your device and browsing activity. We use this data to improve the site, ensure security and deliver personalized content. You can manage your cookie preferences by clicking here.

Accept cookies Configure

Basic cookie information

This website uses cookies and/or similar technologies that store and retrieve information when you browse. In general, these technologies can serve very different purposes, such as, for example, recognizing you as a user, obtaining information about your browsing habits or personalizing the way in which the content is displayed. The specific uses we make of these technologies are described below. By default, all cookies are disabled, except for technical ones, which are necessary for the website to function. If you wish to obtain more information or exercise your data protection rights, you can consult our "Cookie Policy".

Accept cookies Configure

Technical and/or necessary cookies Always active

Technical cookies are those that facilitate user navigation and the use of the different options or services offered by the website, such as identifying the session, allowing access to certain areas, facilitating orders, purchases, filling out forms, registrations, security, facilitating functionalities. (videos, social networks...).

Analysis cookies

Analysis cookies are those used to carry out anonymous analysis of the behavior of web users and that allow user activity to be measured and navigation profiles to be created with the objective of improving websites.

Confirm preferences

Latest updates

Latest news

Press 08/08/2024 OWL Metabolomics contributes to the publication One‐step non‐invasive diagnosis of metabolic dysfunction‐associated steatohepatitis and fibrosis in high‐risk population. Learn more

News 08/07/2024 Quality Management Reinforced with ISO Certifications Learn more

News, Press 20/12/2023 OWL Metabolomics and VCU’s Stravitz-Sanyal Institute Sign Collaboration Agreement for Liver Disease Research Learn more